Prevalence and characteristics of ertapenem-nonsusceptible Escherichia coli in a Taiwanese university hospital, 1999 to 2007

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 29, Issue 11, 2010, Pages 1417-1425

  Yan, J J ^b   Wu, J J ^a   Lee, C C ^a   Ko, W C ^a   Yang, F C ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEMASE; CEPHALOSPORIN; CEPHALOSPORINASE; ERTAPENEM; OUTER MEMBRANE PROTEIN C; OUTER MEMBRANE PROTEIN F; PORIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; ENZYME SYNTHESIS; ESCHERICHIA COLI; HUMAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TAIWAN; UNIVERSITY HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; BETA-LACTAMS; CARBAPENEMS; CEPHALOSPORINASE; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; PORINS; TAIWAN;

EID: 78449259938     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-010-1020-1     Document Type: Article

References (24)

1. SJ Edwards MJ Clarke S Wordsworth CE Emmas 2008 Carbapenems versus other beta-lactams in treating severe infections in intensive care: a systematic review of randomised controlled trials Eur J Clin Microbiol Infect Dis 27 531 543 1:CAS:528:DC%2BD1cXntFKntbg%3D 10.1007/s10096-008-0472-z 18373108
2. P Nordmann G Cuzon T Naas 2009 The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria Lancet Infect Dis 9 228 236 1:CAS:528:DC%2BD1MXkvVSisbg%3D 10.1016/S1473-3099(09)70054-4 19324295
3. AM Queenan K Bush 2007 Carbapenemases: the versatile β-lactamases Clin Microbiol Rev 20 440 458 1:CAS:528:DC%2BD2sXpsFGktbY%3D 10.1128/CMR.00001-07 17630334
4. S Gröbner D Linke W Schütz C Fladerer J Madlung IB Autenrieth W Witte Y Pfeifer 2009 Emergence of carbapenem-non-susceptible extended-spectrum β-lactamase-producing Klebsiella pneumoniae isolates at the university hospital of Tübingen, Germany J Med Microbiol 58 912 922 10.1099/jmm.0.005850-0 19502377
5. DM Livermore R Hope G Brick M Lillie R Reynolds BSAC Working Parties on Resistance Surveillance 2008 Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001-06 J Antimicrob Chemother 62 Suppl 2 ii41 ii54 1:CAS:528:DC%2BD1cXht1eksbzO 10.1093/jac/dkn351 18819979
6. M Doumith MJ Ellington DM Livermore N Woodford 2009 Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK J Antimicrob Chemother 63 659 667 1:CAS:528:DC%2BD1MXjt1Gjtr8%3D 10.1093/jac/dkp029 19233898
7. YF Liu JJ Yan WC Ko SH Tsai JJ Wu 2008 Characterization of carbapenem-non-susceptible Escherichia coli isolates from a university hospital in Taiwan J Antimicrob Chemother 61 1020 1023 1:CAS:528:DC%2BD1cXksF2ltro%3D 10.1093/jac/dkn049 18292097
8. MF Lartigue L Poirel C Poyart H Réglier-Poupet P Nordmann 2007 Ertapenem resistance of Escherichia coli Emerg Infect Dis 13 315 317 1:CAS:528:DC%2BD2sXisVOitL0%3D 10.3201/eid1302.060747 17479901
9. J Oteo A Delgado-Iribarren D Vega V Bautista MC Rodríguez M Velasco JM Saavedra M Pérez-Vázquez S García-Cobos L Martínez-Martínez J Campos 2008 Emergence of imipenem resistance in clinical Escherichia coli during therapy Int J Antimicrob Agents 32 534 537 1:CAS:528:DC%2BD1cXhtlGls7zJ 10.1016/j.ijantimicag.2008.06.012 18775649
10. HM Wexler 2004 In vitro activity of ertapenem: review of recent studies J Antimicrob Chemother 53 Suppl 2 ii11 ii21 1:CAS:528:DC%2BD2cXlvF2nurg%3D 10.1093/jac/dkh204 15150179
11. Clinical and Laboratory Standards Institute (CLSI) (2009) Performance standards for antimicrobial susceptibility testing. Nineteenth informational supplement. CLSI document M100-S19. CLSI, Wayne, PA
12. FC Tenover RD Arbeit RV Goering PA Mickelsen BE Murray DH Persing B Swaminathan 1995 Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing J Clin Microbiol 33 2233 2239 1:CAS:528:DyaK2MXoslSisLc%3D 7494007
13. J Versalovic T Koeuth JR Lupski 1991 Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes Nucleic Acids Res 19 6823 6831 1:CAS:528:DyaK38XnslelsA%3D%3D 10.1093/nar/19.24.6823 1762913
14. JJ Yan WC Ko HM Wu SH Tsai CL Chuang JJ Wu 2004 Complexity of Klebsiella pneumoniae isolates resistant to both cephamycins and extended-spectrum cephalosporins at a teaching hospital in Taiwan J Clin Microbiol 42 5337 5340 1:CAS:528:DC%2BD2cXhtFahtLzJ 10.1128/JCM.42.11.5337-5340.2004 15528737
15. W Song SH Jeong JS Kim HS Kim DH Shin KH Roh KM Lee 2007 Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC β-lactamases and extended-spectrum β-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis Diagn Microbiol Infect Dis 57 315 318 1:CAS:528:DC%2BD2sXisVCgtLo%3D 10.1016/j.diagmicrobio. 2006.08.023 17174510
16. JJ Yan JJ Wu SH Tsai CL Chuang 2004 Comparison of the double-disk, combined disk, and Etest methods for detecting metallo-β-lactamases in gram-negative bacilli Diagn Microbiol Infect Dis 49 5 11 1:CAS:528: DC%2BD2cXjvVertLo%3D 10.1016/j.diagmicrobio.2004.01.002 15135493
17. H Yigit AM Queenan GJ Anderson A Domenech-Sanchez JW Biddle CD Steward S Alberti K Bush FC Tenover 2001 Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae Antimicrob Agents Chemother 45 1151 1161 1:CAS:528:DC%2BD3MXit1Omsrc%3D 10.1128/AAC.45.4.1151-1161.2001 11257029
18. JJ Yan WC Ko SH Tsai HM Wu YT Jin JJ Wu 2000 Dissemination of CTX-M-3 and CMY-2 β-lactamases among clinical isolates of Escherichia coli in southern Taiwan J Clin Microbiol 38 4320 4325 1:CAS:528:DC%2BD3MXislCltLg%3D 11101558
19. JJ Yan WC Ko JJ Wu SH Tsai CL Chuang 2004 Epidemiological investigation of bloodstream infections by extended spectrum cephalosporin-resistant Escherichia coli in a Taiwanese teaching hospital J Clin Microbiol 42 3329 3332 10.1128/JCM.42.7.3329-3332.2004 15243108
20. A Philippon G Arlet GA Jacoby 2002 Plasmid-determined AmpC-type β-lactamases Antimicrob Agents Chemother 46 1 11 1:CAS:528: DC%2BD38XjtVartg%3D%3D 10.1128/AAC.46.1.1-11.2002 11751104
21. L Poirel C Héritier C Spicq P Nordmann 2004 In vivo acquisition of high-level resistance to imipenem in Escherichia coli J Clin Microbiol 42 3831 3833 1:CAS:528:DC%2BD2cXnt1Ogu7o%3D 10.1128/JCM.42.8.3831-3833.2004 15297541
22. H Mammeri P Nordmann A Berkani F Eb 2008 Contribution of extended-spectrum AmpC (ESAC) β-lactamases to carbapenem resistance in Escherichia coli FEMS Microbiol Lett 282 238 240 1:CAS:528:DC%2BD1cXmsFOit70%3D 10.1111/j.1574-6968.2008.01126.x 18371063
23. D Szabó F Silveira AM Hujer RA Bonomo KM Hujer JW Marsh CR Bethel Y Doi K Deeley DL Paterson 2006 Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae Antimicrob Agents Chemother 50 2833 2835 10.1128/AAC.01591-05 16870780
24. VIM endemicity J Antimicrob Chemother 56 761 764 1:CAS:528: DC%2BD2MXhtVKiu7fM 10.1093/jac/dki296 16115825